Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 28, 2017

DrugPatentWatch Database Preview

Ergoloid mesylates - Generic Drug Details

« Back to Dashboard

What are the generic sources for ergoloid mesylates and what is the scope of ergoloid mesylates freedom to operate?

Ergoloid mesylates
is the generic ingredient in eight branded drugs marketed by Kv Pharm, Novartis, Watson Labs, Sun Pharm Inds, 3M, Vangard, Sandoz, Bristol Myers Squibb, Superpharm, Lederle, Ivax Pharms, and Mutual Pharm, and is included in thirty-four NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for ergoloid mesylates. Two suppliers are listed for this compound.

Summary for Generic Name: ergoloid mesylates

Drug Master File Entries: see list4
Suppliers / Packagers: see list2
Therapeutic Class:Antidementia Agents
Drug Prices:see low prices
DailyMed Link:ergoloid mesylates at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs
ergoloid mesylates
TABLET;SUBLINGUAL084930-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
ergoloid mesylates
TABLET;SUBLINGUAL089234-001Sep 23, 1986DISCNNoNo► Subscribe► Subscribe
Kv Pharm
ergoloid mesylates
TABLET;SUBLINGUAL085899-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Sun Pharm Inds
ergoloid mesylates
TABLET;ORAL081113-001Oct 31, 1991ABRXNoNo► Subscribe► Subscribe
ergoloid mesylates
TABLET;SUBLINGUAL084868-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Find generic sources and suppliers
  • Predict branded drug patent expiration
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus